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ABSTRACT
Purpose: We sought to estimate the prevalence of trachoma at sufficiently fine resolution to allow
elimination interventions to begin, where required, in the Southern Nations, Nationalities, and
Peoples’ Region (SNNPR) of Ethiopia.
Methods: We carried out cross-sectional population-based surveys in 14 rural zones. A 2-stage
cluster randomized sampling technique was used. A total of 40 evaluation units (EUs) covering
110 districts (“woredas”) were surveyed from February 2013 to May 2014 as part of the Global
Trachoma Mapping Project (GTMP), using the standardized GTMP training package and
methodology.
Results: A total of 30,187 households were visited in 1047 kebeles (clusters). A total of 131,926
people were enumerated, with 121,397 (92.0%) consenting to examination. Of these, 65,903
(54.3%) were female. In 38 EUs (108 woredas), TF prevalence was above the 10% threshold at
which the World Health Organization recommends mass drug administration with azithromycin
annually for at least 3 years. The region-level age- and sex-adjusted trichiasis prevalence was 1.5%,
with the highest prevalence of 6.1% found in Cheha woreda in Gurage zone. The region-level age-
adjusted TF prevalence was 25.9%. The highest TF prevalence found was 48.5% in Amaro and
Burji woredas. In children aged 1–9 years, TF was associated with being a younger child, living at
an altitude <2500m, living in an area where the annual mean temperature was >15°C, and the use
of open defecation by household members.
Conclusion: Active trachoma and trichiasis are significant public health problems in SNNPR,
requiring full implementation of the SAFE strategy (surgery, antibiotics, facial cleanliness, and
environmental improvement).
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Introduction
Trachoma is the most common infectious cause of
blindness worldwide. Trachoma is thought to be ende-
mic in at least 50 countries,1 and has been targeted for
global elimination as a public health problem by the
year 2020. An estimated 200 million people live in
endemic areas and are at risk of developing trachoma-
related blindness.2 Transmission of the causative agent,
ocular strains of Chlamydia trachomatis, occurs from
eye to eye via hands, clothing and bedding, or via
mechanical transmission by eye-seeking flies.3–5
According to the World Health Organization
(WHO) simplified trachoma grading system, trachoma-
tous inflammation – follicular (TF) and trachomatous
inflammation – intense (TI) are signs of active disease
most commonly found in young children. Following
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repeat infections, scar tissue may form on the conjunc-
tival surfaces of the eyelids; over time these scars can
lead to in-turning of the eyelashes to the point that they
abrade the surface of the globe. This is known as
trachomatous trichiasis.5,6
Trachoma is thought to be endemic throughout
Ethiopia, with the highest prevalences of both active and
potentially blinding trachoma found anywhere in the
world.7 In addition, trachoma is the country’s second
most common cause of blindness overall after cataract.8
The Southern Nations, Nationalities, and Peoples’ Region
(SNNPR) is a central-southern region of Ethiopia, which
covers almost 110,931 km2 or 10% of the country’s land
area. In 2015 it had an estimated 17.8 million inhabitants,
or about a fifth of the country’s population, withmore than
90% living in rural areas.9 The region is divided into 14
administrative zones, four special woredas (districts), and
one city administration, with Hawassa as the regional
capital.
Prior to 2013, there were limited woreda-level data
regarding the distribution of trachoma in SNNPR.
Trachoma intervention programs were already active
in Wolaita and Gamo Gofa zones, and where eye care
non-governmental organizations (NGOs) were work-
ing, trichiasis was commonly managed. However,
large areas of the region had little health care coverage
to provide intelligence on disease occurrence. The
2005–2006 National Survey on Blindness, Low Vision
and Trachoma examined 5415 individuals in 33 kebeles
(the lowest census administrative unit) throughout
SNNPR and found an overall regional prevalence of
active trachoma of 33.2% among children aged 1–9
years. Although this backed previous views that tra-
choma was a significant public health problem in the
region, data at higher resolution were needed to make
intervention decisions.
To guide control programs, WHO recommends dis-
trict-level prevalence data are used, with the TF pre-
valence in children aged 1–9 years used to determine
the need for the A, F and E components of the SAFE
strategy (surgery for trachomatous trichiasis cases, anti-
biotic distribution to clear infection, facial cleanliness,
and environmental improvement). In areas with a TF
prevalence ≥10%, mass administration of azithromycin
is recommended for at least 3 years, together with
measures to encourage facial cleanliness and improve
the sanitation provisions in affected communities.10,11
We carried out Global Trachoma Mapping Project
(GTMP)12-supported population-based trachoma pre-
valence surveys covering all suspected trachoma-ende-
mic woredas without either (1) current control
programs, or (2) population-based prevalence surveys
in the 10 years preceding 2013. The aims were to
estimate the prevalence of TF in children aged 1–9
years, and the prevalence of trichiasis in those aged 15
years and older, to guide future interventions in the
region. We also collected water, sanitation and hygiene
(WASH) data to evaluate risk factors for trachoma.
Materials and methods
Although collection of district-level data is generally
recommended, in areas suspected to be highly and widely
endemic for trachoma, WHO accepts that baseline surveys
may be powered for larger populations, in order to expedite
initiation of interventions where needed.13 Our first phase
of surveyswas designed to estimate prevalence in each of 37
evaluation units (EUs) consisting of 1–8 contiguous,
grouped woredas, with those EUs therefore corresponding
to sub-zones in the local administrative hierarchy. EUs
were constructed in collaboration with local epidemiolo-
gists, respecting local administrative (zonal) boundaries. In
one sub-zone-level EU, we did not find trachoma to be
highly endemic (see below) and extra clusters were subse-
quently added in each of its four constituent woredas, in a
second phase of fieldwork, in order to generate woreda-
level estimates of trachoma prevalence in that sub-zone.
Each EU comprised a total population of up to 250,000
inhabitants. The second phase split of one EU into four EUs
ultimately generated data for a total of 40 EUs, covering 110
woredas over 16 zones (Figure 1). All sampling was carried
out at EU level.
Survey teams
Each team consisted of a trachoma grader, a data recorder
and a driver. All graders and recorders had completed a
standardized GTMP training course (version 1) and passed
a formal examination.14 Training was conducted from 11
February 2013 to 15 February 2013. Trachoma graders
were required to pass an inter-grader agreement test in
the field against a GTMP-certified grader trainer.
Recorders and graders were selected for training by the
SNNPR Regional Health Office. Supervisors (normally
ophthalmologists) who were also GTMP-certified tra-
choma graders or grader trainers, provided support to
3–4 teams throughout the mapping. Subsequent data pro-
cessing and approval were undertaken as described
elsewhere.14
Survey design and sampling
The survey used a 2-stage cluster-randomized meth-
odology outlined in full elsewhere,14 with specific
refinements for use in SNNPR. The first stage cluster
unit was the kebele. Kebeles were selected using
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census data obtained from the regional health bureau,
and were randomly chosen with probability propor-
tional to size. Before the survey was conducted, a
representative of the regional health bureau went to
each selected kebele, and one developmental unit
(DU; a subdivision of a kebele with approximately
30 households) was selected randomly using the lot-
tery method. DUs which had fewer than 26 house-
holds were excluded from the sampling frame. On
the day of the survey, consent was initially obtained
from the village leader, and the village health exten-
sion worker or the DU head was engaged to guide
the teams and to introduce the team to each
household.
Sample size
As described elsewhere14 the sample size needed to
estimate a 10% TF prevalence in children aged 1–9
years with an absolute precision of 3% at the 95%
confidence level (and accounting for the non-indepen-
dence of results in clustered sampling by using a
design effect estimate from previous trachoma surveys
of 2.65) was 1019 1–9-year-olds. This figure was
inflated by 20% to accommodate non-response, giving
an anticipated sample size of 1222 children aged 1–9
years. From the 2007 census data it was estimated that
there would be on average 45 children per DU,
therefore we needed to survey 26 such 30-household
DU clusters in each EU.9
Data collection
All household members at sampled households were eligi-
ble for inclusion. All consenting household members aged
1 year and older were examined for TF, TI and trichiasis
using the WHO simplified trachoma grading system.5,6
Data recorders also collected global positioning system
(GPS) coordinates of each sampled household, and
WASH data by focused interview with the household
head and direct observation of sanitation facilities. WASH
variables collected were consistent with the WHO/
UNICEF Joint Monitoring Programme outcomes.14,15 All
data were collected using Android smartphones with the
Task Force LINKS software (Task Force for Global Health,
Decatur, GA, USA). Data were encrypted and uploaded to
a secure cloud-based server whenmobile network orWi-Fi
reception was available.
Ethical considerations
Ethics clearance was obtained from SNNPRHealth Bureau
Ethical Review Committee, and the Ethics Review
Committee of the Federal Ministry of Health of Ethiopia.
Regional, zone and woreda officials were informed and
provided with support letters for the study. In addition,
Figure 1. Evaluation units of grouped woredas (districts), Global Trachoma Mapping Project, Southern Nations, Nationalities, and
Peoples’ Region, Ethiopia, 2013–2014.
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ethics clearancewas obtained from the Ethics Committee at
the London School of Hygiene & Tropical Medicine (refer-
ence 6319). Verbal informed consent was obtained from
the household head and electronically recorded in LINKS.
All members of households found to have active trachoma
were provided with a course of 1% tetracycline and
instructions on its use. Those who needed further exam-
ination and treatment were referred to the nearest eye care
center using a standardized referral form. Survey teams also
provided general health education on limiting the spread of
trachoma.
Table 1. Demographic characteristics of individuals enumerated, Global Trachoma Mapping Project, Southern Nations, Nationalities,
and Peoples’ Region, Ethiopia, 2013–2014.
Age group, years Sex Examined, n (%) Absent, n (%) Refused, n (%) Other, n (%) Total, n
1–9 Male 21,296 (96.2) 805 (3.6) 44 (0.2) 4 (0.0) 22,149
Female 20,919 (97.5) 508 (2.4) 29 (0.1) 3 (0.0) 21,459
10–14 Male 8113 (88.1) 1074 (11.7) 21 (0.2) 0 (0.0) 9208
Female 7871 (90.9) 761 (8.8) 23 (0.3) 2 (0.0) 8593
≥15 Male 26,085 (82.8) 5333 (16.9) 71 (0.2) 7 (0.0) 31,496
Female 37,113 (95.3) 1767 (4.5) 73 (0.2) 4 (0.0) 38,957
Total 121,397 10,248 261 20 131,926
Table 2. Trachomatous inflammation – follicular (TF) prevalence in children aged 1–9 years by evaluation unit, Global Trachoma
Mapping Project, Southern Nations, Nationalities, and Peoples’ Region, Ethiopia, 2013–2014.
Zone Evaluation unit Examined, n TF cases, n
Unadjusted
TF, %
Adjusteda TF, %
(95% CI)
Hadiya Misha, Anna Lemo, Gibe, Limo 1093 498 45.6 45.0 (38.1–51.8)
Soro, Duna, Gombora 1092 397 36.4 36.0 (28.2–44.9)
Shashego, Yem, Misrak Badawacho, Mirab Badawacho 1189 446 37.5 37.8 (31.6–44.8)
Sidama Dale, Shebedino 837 273 32.6 30.6 (24.3–37.2)
Hawassa Zuria, Boroche, Wenedo Genet 1036 424 40.9 39.5 (31.5–46.9)
Arbegona, Bona Zuria, Bursa, Chirie 1238 251 20.3 17.4 (10.1–24.2)
Dara, Aleta Wendo Town, Loka Abaya, Chiko 962 225 23.4 22.7 (16.7–29.3)
Aroresa, Bensa 1120 324 28.9 27.7 (19.8–37.0)
Gorchie 1029 68 6.6 6.3 (2.7–10.0)
Hula 966 118 12.2 10.1 (5.4–15.0)
Malega 1050 124 11.8 11.8 (7.2–15.3)
Wenesho 900 150 16.7 13.6 (9.1–18.7)
Gedio Kochere, Gedeb, Yergachefe 1299 251 19.3 18.3 (13.2–22.4)
Bule, Wenago, Dilla Zuria 1105 209 18.9 15.0 (9.4–20.1)
South Omo Basketo, South Ari, Semen Ari, Salamago, Debub Ari, North Ari 1072 304 28.4 26.6 (19.5–35.9)
Hamer, Bena Tsemay, Dassenech, Malie, Nyngatom 1043 240 23 20.1 (13.3–27.8)
Sheka Yeki, Masha Anderacha, Masha, Masha Town, Tepi Town 863 110 12.7 12.0 (6.2–18.3)
Kafa Chena, Gesha, Gewata, Gimbo, Saylem 991 426 43.0 40.8 (32.9–48.9)
Bita, Cheta, Decha, Menjiwo, Tello 1036 429 41.4 36.9 (29.1–44.5)
Bench Maji Bero, Shay Bench, Surma, Guraferda, Maji, Meanit Goldiiya, Meint
Shasha, Debub Bench
1115 398 35.7 32.0 (24.4–41.8)
Semen Bench, Sheko, Mizan Aman Town 1212 358 29.5 28.5 (20.1–35.7)
Segen Amaro, Burji 1301 658 50.6 48.5 (41.5–55.9)
East Gurage/
Konta/Dawro
Konta, Isara, Tocha, Mareko 927 330 35.6 35.6 (27.2–44.9)
Dawro Gena Bosa, Loma, Tercha Town 1030 303 29.4 28.1 (21.2–34.0)
Silti Alicho Wuriro, Misirak Azerenert Berbere, Sankura, Mirab
Azerenert Berbere, Wilbareg
984 315 32.0 26.4 (18.0–36.5)
Dalocha, Lamfero, Selti 1191 368 30.9 27.0 (18.6–33.4)
Gamo Gofa Kemba 1158 350 30.2 26.4 (19.1–35.5)
Bonke 1098 193 17.6 15.8 (9.3–24.3)
Arbaminch Town 1018 214 21.0 19.0 (13.5–25.5)
Special Konso 1084 427 39.4 35.5 (28.2–41.9)
Kembata
Tembaro/
Halaba
Halaba Special woreda, Demboya, Kedida-Gamela 1166 524 44.9 41.0 (33.8–48.5)
Angacha, Hadero Tunito, Kacha Bira, Doyugena, Tembaro 1005 323 32.1 29.1 (24.2–35.3)
Gurage Cheha 794 256 32.2 29.1 (22.4–35.4)
Ezha 798 120 15.0 13.9 (9.8–18.9)
Mihur Aklil 784 234 29.8 27.6 (18.2–39.8)
Kebena 959 286 29.8 30.8 (24.5–38.0)
Kokir 958 157 16.4 15.4 (9.8–23.6)
Abeshige 958 155 16.2 14.7 (9.6–20.2)
Sodo 940 400 42.6 41.4 (31.2–49.9)
Geta, Gumer 754 17 2.3 2.3 (0.6–4.8)
aAdjusted for age in 1-year age bands.
CI, confidence interval.
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Environmental risk factors
Cluster-level climatic data thought to be related to tra-
choma were obtained from WorldClim variables (world-
clim.org),16 at a resolution of 2.5 arc-minutes (~5 km).
Altitude was collected from global positioning system
(GPS) data on smartphones at the time of survey. These
measures were considered to possibly associate with like-
lihood of C. trachomatis transmission. Variables consid-
ered for models were altitude, annual mean temperature,
mean annual precipitation, and maximum temperature in
the hottest month.
Data analysis
Briefly, TF estimates in the 1–9-year age range were
adjusted for age in 1-year bands using the 2007 SNNPR
census data.9 Trichiasis estimates were adjusted for both
sex and age in 5-year bands. It was anticipated that by
visiting 30 households per cluster, approximately the
same number of participants would be examined per clus-
ter. However, to account for natural variation in these
numbers, clusters were equally weighted by adjusting at
cluster-level and calculating the arithmetic mean of all such
adjusted cluster estimates, with this mean used as the over-
all EU-level prevalence estimate.14 Confidence intervals
(CIs) around these results were constructed by bootstrap-
ping from these estimates and taking the 2.5th and 97.5th
centiles of 10,000 bootstrap replicates.
Adjusted results and CIs were produced using R
3.0.2 (2013; The R Foundation for Statistical
Computing, Vienna, Austria). Point values for climatic
variables were extracted from rasters using ArcGIS 10.3
(Spatial Analyst; Environmental Systems Research
Institute, Redlands, CA, USA). Risk factor analysis
was carried out in Stata 10.2 (Stata Corp, College
Station, TX, USA). Co-linearity was assessed using
Mantel-Haenszel tests of association, but not used as
an absolute exclusion criterion. A multi-level hierarch-
ical model was used to account for clustering at kebele
and household level. Univariable associations were
assessed and variables were retained for the multivari-
able model if significant at the p < 0.05 level (Wald’s
test). The full model was developed by a stepwise inclu-
sion approach with variables retained if statistically
significant at the p < 0.05 level (likelihood ratio test).
Results
The first phase of 37 sub-zone-level surveys (covering
110 woredas) was carried out from 18 February to 10
June 2013. One EU, comprising four woredas (Gorchie,
Hula, Malega, Wenesho) was found to have a TF pre-
valence between 5% and 10%, so in a second phase,
these four woredas were further mapped as four EUs at
woreda-level, using the same methodology previously
applied at sub-zonal level. This meant adding clusters
to each constituent woreda to reach the required
Figure 2. Prevalence of trachomatous inflammation – follicular (TF) in children aged 1–9 years, Global Trachoma Mapping Project,
Southern Nations, Nationalities, and Peoples’ Region, Ethiopia, 2013–2014.
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sample size. We undertook this second phase from 3
April 2014 to 23 May 2014.
Overall, 14 rural zones of SNNPR were included in
the surveys. A total of 40 EUs covering 113 woredas
were ultimately surveyed. A total of 30,187 households
were visited in 1047 kebeles, with 131,926 people
enumerated, and 121,397 (92.0%) consenting to exam-
ination. Of those examined, 65,903 (54.3%) were
female. There was a median of four inhabitants per
household (interquartile range, IQR, 3–6), and a med-
ian of one child aged 1–9 years per household (IQR
0–2). The demographic characteristics of all individuals
enumerated are outlined in Table 1.
The age-adjusted EU-level prevalence of TF in chil-
dren aged 1–9 years ranged from 2.3% (95% CI 0.6–
4.8%) in Geta and Gumer woredas of Gurage Zone, to
48.5% (95% CI 41.5–55.9%) in Amaro and Burji in
Segen Zone. There were only two EUs which had TF
prevalences below 10%; Geta and Gumer, and Gorchie
woreda in Sidama. All other EUs had TF prevalences
≥10% (Table 2, Figure 2).
The age- and sex-adjusted prevalences of trichiasis
in those aged 15 years and older ranged from 0.0%
(95% CI 0.0–0.1%) in Hula woreda of Sidama Zone,
to 6.1% (95% CI 4.4–7.8%) in Cheha in Gurage Zone.
The trichiasis prevalence in those aged 15 years and
Table 3. Trichiasis prevalence in those aged ≥15 years by evaluation unit, Global Trachoma Mapping Project, Southern Nations,
Nationalities, and Peoples’ Region, Ethiopia, 2013–2014.
Examined age 15 years or greater
Zone Evaluation unit
Examined,
n
Trichiasis
cases, n
Unadjusted
TT, %
Adjusteda TT, %
95% CI
Hadiya Misha, Anna Lemo, Gibe, Limo 1649 54 3.3 2.1 (1.3–2.7)
Soro, Duna, Gombora 1674 74 4.4 2.6 (1.5–4.1)
Shashego, Yem, Misrak Badawacho, Mirab Badawacho 1615 70 4.3 3.0 (2.0–4.2)
Sidama Dale, Shebedino 1686 34 2.0 1.6 (0.9–2.5)
Hawassa Zuria, Boroche, Wenedo Genet 1592 27 1.7 1.1 (0.5–1.9)
Arbegona, Bona Zuria, Bursa, Chirie 1466 3 0.2 0.1 (0.0–0.1)
Dara, Aleta Wendo Town, Loka Abaya, Chiko 1596 9 0.6 0.5 (0.1–1.0)
Aroresa, Bensa 1558 9 0.6 0.4 (0.1–0.6)
Gorchie 1506 2 0.1 0.1 (0.0–0.1)
Hula 1478 2 0.1 0.0 (0.0–0.1)
Malega 1370 7 0.5 0.3 (0.0–0.5)
Wenesho 1528 8 0.5 0.3 (0.0–0.6)
Gedio Kochere, Gedeb, Yergachefe 1614 17 1.1 0.8 (0.3–1.5)
Bule, Wenago, Dilla Zuria 1456 22 1.5 0.7 (0.4–1.0)
South Omo Basketo, South Ari, Semen Ari, Salamago, Debub Ari, North Ari 1205 13 1.1 0.6 (0.1–1.2)
Hamer, Bena Tsemay, Dassenech, Malie, Nyngatom 1215 26 2.1 1.1 (0.5–1.5)
Sheka Yeki, Masha Anderacha, Masha, Masha Town, Tepi Town 1987 21 1.1 0.7 (0.3–1.1)
Kafa Chena, Gesha, Gewata, Gimbo, Saylem 1727 25 1.4 1.1 (0.5–1.9)
Bita, Cheta, Decha, Menjiwo, Tello 1592 22 1.4 0.9 (0.5–1.4)
Bench Maji Bero, Shay Bench, Surma, Guraferda,Maji, Meanit Goldiiya, Meint
Shasha, Debub Bench
1306 11 0.8 0.6 (0.2–1.1)
Semen Bench, Sheko, Mizan Aman Town 1470 15 1.0 0.8 (0.3–1.3)
Segen Amaro, Burji 1500 59 3.9 2.6 (1.6–3.4)
East Gurage/Konta/
Dawro
Konta, Isara, Tocha, Mareko 1462 58 4.0 2.3 (1.4–3.1)
Dawro Gena Bosa, Loma, Tercha Town 1620 34 2.1 1.2 (0.8–1.7)
Silti Alicho Wuriro, Misirak Azerenert Berbere, Sankura, Mirab Azerenert
Berbere, Wilbareg
1434 27 1.9 0.8 (0.4–1.4)
Dalocha, Lamfero, Selti 1468 52 3.5 2.0 (1.3–2.7)
Gamo Gofa Kemba 1456 28 1.9 1.1 (0.5–1.8)
Bonke 1481 27 1.8 1.2 (0.7–1.9)
Arbaminch Town 1416 31 2.2 0.8 (0.5–1.2)
Special Konso 1394 33 2.4 1.0 (0.7–1.4)
Kembata Tembaro/
Halaba
Halaba Special woreda, Demboya, Kedida-Gamela 1559 53 3.4 2.0 (1.3–2.7)
Angacha, Hadero Tunito, Kacha Bira, Doyugena, Tembaro 1640 77 4.7 3.1 (2.3–3.8)
Gurage Cheha 1606 184 11.5 6.1 (4.4–7.8)
Ezha 1895 97 5.1 2.2 (1.4–3.3)
Mihur Aklil 1488 98 6.6 4.3 (2.8–6.3)
Kebena 1546 125 8.1 4.5 (3.1–6.2)
Kokir 1425 35 2.5 1.6 (1.0–2.5)
Abeshige 1730 80 4.6 3.3 (2.2–4.5)
Sodo 1473 49 3.3 1.4 (0.7–2.0)
Geta, Gumer 1830 17 0.9 0.3 (0.1–0.6)
Adjusted for sex and age in 5-year age bands.
CI, confidence interval.
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older was 0.2% or less in three EUs covering six
woredas in Sidama Zone; Arbergona, Bona Zuria,
Bursa, Chirie, Gorchie and Hula (Table 3, Figure 3).
Multilevel clustering of TF and TI
Null models for both TF and TI adjusted for age and
sex showed statistically significant clustering at EU,
kebele (cluster) and household levels. For TF, the esti-
mated standard deviation for between-EU clustering
was 2.78 (standard error, SE, 1.13, p < 0.0001), for
between-kebele clustering was 4.08 (SE 1.04, p <
0.0001), and for between-household clustering was 3.0
(SE 1.03, p < 0.0001). For TI, the estimated standard
deviation for between-EU clustering was 2.0 (SE 1.1, p
= 0.001), for between-kebele clustering was 3.17 (SE
1.06, p < 0.0001), and for between-household clustering
was 3.16 (SE 1.06, p < 0.0001). For both TF and TI,
clustering was strongest at kebele level, and all subse-
quent analyses were conducted as 2-level hierarchical
regression models with adjustment for the kebele
inhabited by examined individuals.
Risk factors and climatic variables
Climatic data were extracted from the raster data for all
1047 clusters. The median annual mean temperature over
all clusters was 18.0°C (IQR 16.0–19.4°C), the median
annual maximum temperature was 27.2°C (IQR 24.7–
28.8°C), and the median annual mean precipitation was
1240mm (IQR 1124–1453mm). The median cluster-level
altitude was 1984m (IQR 1769–2427m).
The full results of univariable analysis are shown in
Table 4. In the full multivariable model (Table 5), factors
independently associated with TF and TI in children aged
1–9 years were being a younger child, living at an altitude
<2500m, and living in an area where the annual mean
temperature was above 15°C. Additionally, the use of
open defecation by adult household members was asso-
ciated with TF, but not TI, in children aged 1–9 years.
Discussion
Trachoma is clearly a major public health problem in
SNNPR. A total of 38 of 40 EUs surveyed had TF
prevalences above the 10% threshold at which WHO
recommends population-level distribution of antibio-
tics for 3 years before re-survey. One of 37 sub-zone-
sized EUs had a TF prevalence between 5.0% and 9.9%
in the first phase, and was re-mapped at woreda level in
the second phase; three of four constituent woredas had
TF prevalences above 10%, while the fourth had a TF
prevalence between 5.0% and 9.9%. The final EU (com-
posed of two woredas) had a TF prevalence of 2.3%,
below the elimination threshold for TF. This means
that in SNNPR, 108 woredas require mass drug
Figure 3. Prevalence of trichiasis in those aged ≥15 years, Global Trachoma Mapping Project, Southern Nations, Nationalities, and
Peoples’ Region, Ethiopia, 2013–2014.
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administration (MDA) with azithromycin for at least 3
years, plus implementation of the F and E components
of the SAFE strategy, before impact surveys. Overall, 15
of the 38 EUs (48 woredas) had TF prevalences above
30% and will require MDA for at least 5 years before
impact surveys are needed.
The reason for the density of hyper-endemic woredas
in SNNPR is unclear, and the risk factor analysis did not
help much to generate hypotheses. Younger children
have been associated with higher odds of trachoma in
many previous studies.17–19 In addition, open defecation
is thought to increase infection transmission by provid-
ing an ecological niche for eye-seeking flies known to
carry C. trachomatis.20,21 Trachoma has been associated
with altitude before,21 but the finding in these surveys of
a lower odds of trachoma at high (≥2500m) altitudes is
difficult to explain. It has previously been suggested that
at higher altitudes, lower temperatures decrease fly
activity,22 but why this would cause an effect indepen-
dent of temperature at low altitude is unclear. It is
Table 4. Multilevel univariable analysis of factors related to trachomatous inflammation – follicular (TF) and trachomatous
inflammation – intense (TI) in children aged 1–9 years, Global Trachoma Mapping Project, Southern Nations, Nationalities, and
Peoples’ Region, Ethiopia, 2013–2014.
TF TI
Variable Examined, n % Odds ratioa (95% CI) % Odds ratioa (95% CI)
Individual
Age, years
1–4 17,649 36.4 2.66 (2.53–2.81) 5.3 2.40 (2.16–2.68)
5–9 25,960 20.5 1 (reference) 2.4 1 (reference)
Sex
Male 22,149 26.9 1 (reference) 3.5 1 (reference)
Female 21,459 27.0 1.01 (0.97–1.06) 3.7 0.89 (0.77–1.02)
Household
Children aged 1–9 years in household, n
1–3 34,061 27.2 1 (reference) 3.7 1 (reference)
≥4 9547 26.0 1.02 (0.96–1.09) 3.3 0.89 (0.78–1.02)
Inhabitants in household, n
1–7 36,477 27.8 1 (reference) 3.6 1 (reference)
≥8 7131 22.6 0.91 (0.85–1.02) 3.2 0.97 (0.82–1.14)
Time to main source of drinking water, minutes
<30 20,378 26.7 1 (reference) 3.8 1 (reference)
≥30 23,230 27.2 0.97 (0.90–1.05) 3.4 0.94 (0.81–1.09)
Time to main source of water used for face-washing, minutes
All washing at source 112 28.6 1.02 (0.43–2.39) 6.3 2.81 (0.69–11.27)
<30 21,996 26.4 1 (reference) 3.8 1 (reference)
≥30 21,500 27.4 1.00 (0.93–1.08) 3.3 0.90 (0.77–1.04)
Surface waterb used as drinking source
Yes 5296 30.5 1.19 (1.03–1.38) 4.6 1.21 (0.95–1.55)
No 38,312 26.4 1 (reference) 3.4 1 (reference)
Surface waterb used for face-washing
Yes 8018 28.4 1.11 (0.99–1.24) 4.5 1.29 (1.06–1.58)
No 35,590 26.6 1 (reference) 3.4 1 (reference)
Latrine typec
Improved latrine 2367 23.8 1 (reference) 3.0 1 (reference)
Unimproved latrine 33,937 26.3 1.07 (0.93–1.22) 3.5 1.10 (0.83–1.46)
Open defecation (no facilities, bush, or field) 7304 31.1 1.18 (1.02–1.37) 4.1 1.28 (0.95–1.76)
Kebele (cluster)
Altituded, m above sea level
<2500 34,696 31.5 1 (reference) 4.3 1 (reference)
≥2500 8883 8.9 0.21 (0.17–0.25) 0.8 0.18 (0.13–0.24)
Mean annual precipitatione, mm
<1000 6403 35.4 2.01 (1.54–2.63) 4.7 1.66 (1.23–2.24)
1000–1499 27,968 24.5 1 (reference) 3.2 1 (reference)
≥1500 9237 28.5 1.41 (1.13–1.77) 4.0 1.44 (1.11–1.85)
Mean annual temperaturee, ◦C
<15 7724 7.0 0.10 (0.08–0.13) 0.8 0.16 (0.11–0.23)
≥15 35,884 31.2 1 (reference) 4.2 1 (reference)
Maximum temperature of warmest monthe, °C
<25 11,150 12.3 0.18 (0.15-0.22) 1.2 0.23 (0.18-0.31)
≥25 32,458 32.0 1 (reference) 4.4 1 (reference)
aMultilevel univariable random effects regression accounting for clustering at kebele-level, with 95% CI; p-value from Wald’s test; variables significant at the p
< 0.10 level are shown in bold.
bRiver, dam, lake, canal.
cWHO/UNICEF Joint Monitoring Programme improved sanitation definitions; open defecation displayed separately.
dEstimate from GPS coordinates of household measured on smartphones at the time of survey.
eEstimate from GPS coordinates of household, extracted at kebele(cluster)-level from Bioclim rasters (Worldclim.org).
CI, confidence interval; WHO, World Health Organization; GPS, global positioning system.
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possible that lower altitudes in SNNPR provide a climate
where people are more likely to settle, and so human
population density may be an important association in
these areas.
The prevalence of trichiasis throughout SNNPR was
high. In 37 of 40 EUs (104 woredas) the prevalence was
higher than the elimination prevalence target (set by
WHO) of <0.2% in the population 15 years of age and
older.23 It is likely that without robust interventions being
rapidly put in place, many people will go blind in SNNPR
in the coming years as they wait for surgery. This warrants
the development and maintenance of a strong program
that will address the backlog of patients with trichiasis. To
illustrate the magnitude of the undertaking required, 184
cases of trichiasis were identified in the EU covering Cheha
woreda alone, giving an estimated trichiasis prevalence of
6.1% of the adult population there. Cheha has been known
as a trachoma hotspot for many years, and eye care NGOs
have been targeting trichiasis surgery outreach programs
there since as early as 2006, yet even now, the prevalence is
still among the highest trichiasis prevalence estimates ever
reported. The reason that Cheha should have such a large
trichiasis burden is unclear, but research may be helpful to
guide the regional program as it seeks to recruit, train and
deploy trichiasis surgeons to address it, and to understand
the barriers that people in these areas have to seeking
healthcare.
Our use of EUs generally comprising multiple woredas
allowed us to more rapidly complete baseline mapping of
SNNPR than if each woreda had been approached as an
individual EU. However, as interventions decrease TF
prevalence, it is likely that impact surveys will need to be
carried out at higher resolution, in other words, at woreda-
level. This will require a significant increase in funding to
support the trachoma elimination effort in SNNPR.
Active and potentially blinding trachoma are highly
prevalent throughout SNNPR, and in 108 woredas the
disease presents a significant public health problem.
Political support, coordination and funding for trachoma
elimination are all urgently required.
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Variable TF model TI model
Odds ratioa (95% CI) P-valueb Odds ratioa (95% CI) P-valueb
Age, years <0.0001 <0.0001
1–4 2.65 (2.52–2.79) 2.38 (2.13–2.65)
5–9 1 (reference) 1 (reference)
Mean annual temperaturec, °C <0.0001 0.001
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Improved latrine 1 (reference) 1 (reference)
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bLikelihood ratio test.
cEstimate from GPS coordinates of household, extracted at kebele-level from Bioclim rasters (Worldclim.org).
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fNot included in final TI model, but presented for illustrative purposes.
CI, confidence interval; WHO, World Health Organization; GPS, global positioning system.
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